The Trump administration appears to be expanding RSV vaccinations to some adults starting at age 50, down from 60, following ...

Respiratory syncytial virus is common but it can be dangerous for some infants and young kids. Here's everything parents need ...

The eight new ACIP members met for the first time June 25 after Kennedy fired all 17 original members of the committee June 9 ...

A newly configured federal vaccine panel's June 25 action is expected to improve options to protect infants from potentially ...

A CDC advisory panel on Thursday voted 5-2 to recommend the use of a new preventative RSV therapy in babies, Merck’s ...

The CDC's newly reconstituted Advisory Committee on Immunization Practices (ACIP) voted 5-2 in support of infants younger ...

Merck's Enflonsia vaccine for respiratory syncytial virus won approval from the Centers for Disease Control and Prevention's ...

The ACIP is recommending the use of Enflonsia for the prevention of RSV lower respiratory tract disease in infants younger than 8 months.

The CDC's vaccine advisory committee voted on Thursday to recommend infants receive a newer monoclonal antibody shot for ...

Discover how Professor Shabir Madhi is advancing maternal vaccines to safeguard newborns from RSV, GBS, and more.

An outside group of experts agreed that the CDC should recommend a new antibody drug that offers protection against RSV for ...